Quality of evidence considered by Health Canada in granting full market authorisation to new drugs with a conditional approval: a retrospective cohort study.
about
Quality of evidence considered by Health Canada in granting full market authorisation to new drugs with a conditional approval: a retrospective cohort study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Quality of evidence considered ...... a retrospective cohort study.
@en
Quality of evidence considered ...... a retrospective cohort study.
@nl
type
label
Quality of evidence considered ...... a retrospective cohort study.
@en
Quality of evidence considered ...... a retrospective cohort study.
@nl
prefLabel
Quality of evidence considered ...... a retrospective cohort study.
@en
Quality of evidence considered ...... a retrospective cohort study.
@nl
P2860
P1433
P1476
Quality of evidence considered ...... a retrospective cohort study.
@en
P2093
Joel Lexchin
P2860
P304
P356
10.1136/BMJOPEN-2017-020377
P50
P577
2018-04-28T00:00:00Z